Alerts will be sent to your verified email
Verify EmailSANDUPHQ
Sandu Pharmaceutical
|
ANG Lifesciences
|
Roopa Industries
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
3.94 % | 3.78 % | 7.44 % |
5yr average Equity Multiplier
|
1.34 | 3.3 | 3.94 |
5yr Average Asset Turnover Ratio
|
1.27 | 0.77 | 0.96 |
5yr Avg Net Profit Margin
|
2.31 % | -2.26 % | 1.95 % |
Price to Book
|
1.07 | 0.72 | 2.46 |
P/E
|
28.73 | 0.0 | 21.01 |
5yr Avg Cash Conversion Cycle
|
27.73 Days | 70.26 Days | 81.21 Days |
Inventory Days
|
71.51 Days | 107.37 Days | 134.46 Days |
Days Receivable
|
26.2 Days | 274.82 Days | 39.97 Days |
Days Payable
|
79.23 Days | 235.98 Days | 120.3 Days |
5yr Average Interest Coverage Ratio
|
28.27 | 1.81 | 1.89 |
5yr Avg ROCE
|
5.77 % | 15.08 % | 15.46 % |
5yr Avg Operating Profit Margin
|
3.87 % | 7.68 % | 6.85 % |
5 yr average Debt to Equity
|
0.0 | 0.97 | 1.27 |
5yr CAGR Net Profit
|
-1.69 % | n/a | 32.66 % |
5yr Average Return on Assets
|
2.94 % | 1.04 % | 1.87 % |
Shareholdings
|
|||
Promoter Holding
|
42.9 % | 70.6 % | 48.03 % |
Share Pledged by Promoters
|
0.0 | 44.88 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-7.53 % | -0.55 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Sandu Pharmaceutical
|
ANG Lifesciences
|
Roopa Industries
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|